These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 37373222)
1. The Role of EMT-Related lncRNAs in Ovarian Cancer. Lampropoulou DI; Papadimitriou M; Papadimitriou C; Filippou D; Kourlaba G; Aravantinos G; Gazouli M Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373222 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in gynecologic cancers. Lin X; Qiu J; Hua K Biosci Trends; 2018 Sep; 12(4):342-353. PubMed ID: 30146551 [TBL] [Abstract][Full Text] [Related]
3. Regulatory effects of lncRNAs and miRNAs on the crosstalk between autophagy and EMT in cancer: a new era for cancer treatment. Si L; Yang Z; Ding L; Zhang D J Cancer Res Clin Oncol; 2022 Mar; 148(3):547-564. PubMed ID: 35083552 [TBL] [Abstract][Full Text] [Related]
4. MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer. Xu H; Mao HL; Zhao XR; Li Y; Liu PS J Ovarian Res; 2020 Mar; 13(1):31. PubMed ID: 32192508 [TBL] [Abstract][Full Text] [Related]
5. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs. Zhao Q; Fan C BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053 [TBL] [Abstract][Full Text] [Related]
6. The Emerging Role of EMT-related lncRNAs in Therapy Resistance and their Applications as Biomarkers. Kichi ZA; Soltani M; Rezaei M; Shirvani-Farsani Z; Rojhannezhad M Curr Med Chem; 2022; 29(26):4574-4601. PubMed ID: 35352644 [TBL] [Abstract][Full Text] [Related]
7. Systematic analyses reveal long non-coding RNA (PTAF)-mediated promotion of EMT and invasion-metastasis in serous ovarian cancer. Liang H; Zhao X; Wang C; Sun J; Chen Y; Wang G; Fang L; Yang R; Yu M; Gu Y; Shan H Mol Cancer; 2018 Jun; 17(1):96. PubMed ID: 29929545 [TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA and Epithelial Mesenchymal Transition in Cancer. Gugnoni M; Ciarrocchi A Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003545 [TBL] [Abstract][Full Text] [Related]
9. LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms. Braga EA; Fridman MV; Moscovtsev AA; Filippova EA; Dmitriev AA; Kushlinskii NE Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238475 [TBL] [Abstract][Full Text] [Related]
10. Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling. Tan WX; Sun G; Shangguan MY; Gui Z; Bao Y; Li YF; Jia ZH Sci Rep; 2020 Sep; 10(1):14768. PubMed ID: 32901049 [TBL] [Abstract][Full Text] [Related]
11. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma. Tao C; Luo H; Chen L; Li J; Zhu X; Huang K Bioengineered; 2021 Dec; 12(1):4016-4031. PubMed ID: 34288803 [TBL] [Abstract][Full Text] [Related]
12. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer. Yan H; Li H; Silva MA; Guan Y; Yang L; Zhu L; Zhang Z; Li G; Ren C J Exp Clin Cancer Res; 2019 Aug; 38(1):356. PubMed ID: 31412903 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNAs orchestrate various molecular and cellular processes by modulating epithelial-mesenchymal transition in head and neck squamous cell carcinoma. Sharma A; Kansara S; Mahajan M; Yadav B; Garg M; Pandey AK Biochim Biophys Acta Mol Basis Dis; 2021 Nov; 1867(11):166240. PubMed ID: 34363933 [TBL] [Abstract][Full Text] [Related]
14. The expression of long non-coding RNA LINC01389, LINC00365, RP11-138J23.1, and RP11-354K4.2 in gastric cancer and their impacts on EMT. Taghehchian N; Farshchian M; Mahmoudian RA; Asoodeh A; Abbaszadegan MR Mol Cell Probes; 2022 Dec; 66():101869. PubMed ID: 36208698 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNAs in recurrent ovarian cancer: Theranostic perspectives. Bhardwaj V; Tan YQ; Wu MM; Ma L; Zhu T; Lobie PE; Pandey V Cancer Lett; 2021 Apr; 502():97-107. PubMed ID: 33429007 [TBL] [Abstract][Full Text] [Related]
16. Insights into Biological Role of LncRNAs in Epithelial-Mesenchymal Transition. Cheng JT; Wang L; Wang H; Tang FR; Cai WQ; Sethi G; Xin HW; Ma Z Cells; 2019 Sep; 8(10):. PubMed ID: 31575017 [TBL] [Abstract][Full Text] [Related]
17. Role of lncRNAs as Novel Biomarkers and Therapeutic Targets in Ovarian Cancer. Fu LL; Li CJ; Xu Y; Li LY; Zhou X; Li DD; Chen SX; Wang FG; Zhang XY; Zheng LW Crit Rev Eukaryot Gene Expr; 2017; 27(2):183-195. PubMed ID: 28845767 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNAs AC026904.1 and UCA1: a "one-two punch" for TGF-β-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer. Li GY; Wang W; Sun JY; Xin B; Zhang X; Wang T; Zhang QF; Yao LB; Han H; Fan DM; Yang AG; Jia LT; Wang L Theranostics; 2018; 8(10):2846-2861. PubMed ID: 29774079 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis. Sun Z; Gao S; Xuan L; Liu X J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030 [TBL] [Abstract][Full Text] [Related]
20. Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy. Ashrafizadeh M; Shahinozzaman M; Orouei S; Zarrin V; Hushmandi K; Hashemi F; Kumar A; Samarghandian S; Najafi M; Zarrabi A Curr Cancer Drug Targets; 2021; 21(8):640-665. PubMed ID: 33535952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]